Laryngopharyngeal reflux (LPR) is a common illness of otolaryngology visits. Over the past few years, pepsin has become a promising marker of LPR. The objective of the present research is to analyze the existing literature using pepsin as a diagnostic tool of LPR through a systematic review.
Data Sources
PubMed (Medline), Trip Database, Cochrane Library, EMBASE, SUMsearch, and Web of Science.
Review Methods
The outcome assessed was the presence of pepsin in LPR patients. We included articles in which pepsin was studied in LPR patients (clinically suspected or with confirmed diagnosis). Studies with no control group, comparison group, and/or a sample size lower than 20 patients were excluded.
Results
Twelve studies were included. All included studies, with the exception of 2, found statistically significant differences for pepsin in cases compared with healthy controls.
Conclusion
Pepsin might be a reliable marker in LPR patients, although questions remain about optimal timing, location, nature, and threshold values for pepsin testing. Future investigations are necessary to clarify the best method to use pepsin in the diagnostic process of LPR.
KoufmanJA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope. 1991;101(4, pt 2)(suppl 53):1-78.
2.
HayatJOYazakiEMooreATet al. Objective detection of esophagopharyngeal reflux in patients with hoarseness and endoscopic signs of laryngeal inflammation. J Clin Gastroenterol. 2014;48:318-327.
3.
VaeziMFSchroederPLRichterJE. Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring. Am J Gastroenterol. 1997;92:825-829.
4.
ReichelOIssingWJ. Impact of different pH thresholds for 24-hour dual probe pH monitoring in patients with suspected laryngopharyngeal reflux. J Laryngol Otol. 2008;122:485-489.
5.
BelafskyPCPostmaGNKoufmanJA. Validity and reliability of the reflux symptom index (RSI). J Voice. 2002;16:274-277.
6.
BelafskyPCPostmaGNKoufmanJA. The validity and reliability of the reflux finding score (RFS). Laryngoscope. 2001;111:1313-1317.
7.
KarkosPDWilsonJA. Empiric treatment of laryngopharyngeal reflux with proton pump inhibitors: a systematic review. Laryngoscope. 2006;116:144-148.
8.
ParkKHChoiSMKwonSUKYoonSWKimSUK. Diagnosis of laryngopharyngeal reflux among globus patients. Otolaryngol Head Neck Surg. 2006;134:81-85.
9.
BranskiRCBhattacharyyaNShapiroJ. The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease. Laryngoscope. 2002;112:1019-1024.
10.
VaeziMF. Gastroesophageal reflux disease and the larynx. J Clin Gastroenterol. 2003;36:198-203.
11.
CohenSMKimJRoyNCoureyM. Prescribing patterns of primary care physicians and otolaryngologists in the management of laryngeal disorders. Otolaryngol Head Neck Surg. 2013;149:118-125.
12.
FrancisDORymerJASlaughterJCet al. High economic burden of caring for patients with suspected extraesophageal reflux. Am J Gastroenterol. 2013;108:905-911.
13.
VaeziMFHicksDMAbelsonTIRichterJE. Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroenterol Hepatol. 2003;1:333-344.
14.
KoufmanJAAvivJECasianoRRShawGY. Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology—Head and Neck Surgery. Otolaryngol Head Neck Surg. 2002;127:32-35.
15.
JohnstonNDettmarPWBishwokarmaBLivelyMOKoufmanJA. Activity/stability of human pepsin: implications for reflux attributed laryngeal disease. Laryngoscope. 2007;117:1036-1039.
16.
JohnstonNWellsCWBluminJHToohillRJMeratiAL. Receptor-mediated uptake of pepsin by laryngeal epithelial cells. Ann Otol Rhinol Laryngol. 2007;116:934-938.
17.
JohnstonNWellsCWSamuelsTLBluminJH. Rationale for targeting pepsin in the treatment of reflux disease. Ann Otol Rhinol Laryngol. 2010;119:547-558.
18.
JohnstonNDettmarPWLivelyMOet al. Effect of pepsin on laryngeal stress protein (Sep70, Sep53, and Hsp70) response: role in laryngopharyngeal reflux disease. Ann Otol Rhinol Laryngol. 2006;115:47-58.
19.
SamuelsTLJohnstonN. Pepsin as a causal agent of inflammation during nonacidic reflux. Otolaryngol Head Neck Surg. 2009;141:559-563.
20.
JohnstonNKnightJDettmarPWLivelyMOKoufmanJ. Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease. Laryngoscope. 2004;114:2129-2134.
21.
VaeziMFSlaughterJCSmithBSet al. Dilated intercellular space in chronic laryngitis and gastro-oesophageal reflux disease: at baseline and post-lansoprazole therapy. Aliment Pharmacol Ther. 2010;32:916-924.
22.
YadlapatiRAdkinsCJaiyeolaDMet al. Abilities of oropharyngeal pH tests and salivary pepsin analysis to discriminate between asymptomatic volunteers and subjects with symptoms of laryngeal irritation. Clin Gastroenterol Hepatol. 2016;14:535-542.e2.
23.
KomatsuYKellyLAZaidiAHet al. Hypopharyngeal pepsin and Sep70 as diagnostic markers of laryngopharyngeal reflux: preliminary study. Surg Endosc. 2015;29:1080-1087.
24.
NaSYKwonOELeeYCEunYG. Optimal timing of saliva collection to detect pepsin in patients with laryngopharyngeal reflux. Laryngoscope. 2016;126:2770-2773.
25.
FortunatoJED’AgostinoRBLivelyMO. Pepsin in saliva as a biomarker for oropharyngeal reflux compared with 24-hour esophageal impedance/pH monitoring in pediatric patients [published online September7, 2016]. Neurogastroenterol Motil.
26.
IannellaGDi NardoGPlaterotiRet al. Investigation of pepsin in tears of children with laryngopharyngeal reflux disease. Int J Pediatr Otorhinolaryngol. 2015;79:2312-2315.
27.
Sereg-BaharMJerinAJansaRStabucBHocevar-BoltezarI. Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux—a prospective comparative study. Clin Otolaryngol. 2015;40:234-239.
28.
BirtićDVcevaAKotromanovićZZubcićZMihaljHJovanovićS. Significance of the pepsin from the saliva in the diagnosis and treatment of laryngopharyngeal reflux disease. Coll Antropol. 2012;36(suppl 2):83-86.
29.
JiangALiangMSuZet al. Immunohistochemical detection of pepsin in laryngeal mucosa for diagnosing laryngopharyngeal reflux. Laryngoscope. 2011;121:1426-1430.
30.
WangLLiuXLiuYet al. Correlation of pepsin-measured laryngopharyngeal reflux disease with symptoms and signs. Otolaryngol Head Neck Surg. 2010;143:765-771.
31.
KimTHLeeKJYeoMKimDKChoSW. Pepsin detection in the sputum/saliva for the diagnosis of gastroesophageal reflux disease in patients with clinically suspected atypical gastroesophageal reflux disease symptoms. Digestion. 2008;77:201-206.
32.
Saritas YukselEHongS-KSStrugalaVet al. Rapid salivary pepsin test: blinded assessment of test performance in gastroesophageal reflux disease. Laryngoscope. 2012;122:1312-1316.
33.
SafeMChoJKrishnanU. Combined multichannel intraluminal impedance and pH measurement in detecting gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr. 2016;63:e98-e106.
34.
DyFAmiraultJMitchellPDRosenR. Salivary pepsin lacks sensitivity as a diagnostic tool to evaluate extraesophageal reflux disease. J Pediatr. 2016;177:53-58.
35.
HayatJOGabieta-SomnezSYazakiEet al. Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease. Gut. 2015;64:373-380.
36.
KnightJLivelyMOJohnstonNDettmarPWKoufmanJA. Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux. Laryngoscope. 2005;115:1473-1478.
37.
WassenaarEJohnstonNMeratiAet al. Pepsin detection in patients with laryngopharyngeal reflux before and after fundoplication. Surg Endosc. 2011;25:3870-3876.
38.
GillGAJohnstonNBudaAet al. Laryngeal epithelial defenses against laryngopharyngeal reflux: investigations of E-cadherin, carbonic anhydrase isoenzyme III, and pepsin. Ann Otol Rhinol Laryngol. 2005;114:913-921.
